Literature DB >> 19812259

Specific serodiagnosis of canine visceral leishmaniasis using Leishmania species ribosomal protein extracts.

Eduardo A F Coelho1, Laura Ramírez, Mariana A F Costa, Vinicio T S Coelho, Vivian T Martins, Miguel A Chávez-Fumagalli, Dulcilene M Oliveira, Carlos A P Tavares, Pedro Bonay, Carlos Gómez Nieto, Daniel R Abánades, Carlos Alonso, Manuel Soto.   

Abstract

In the present work, we have analyzed the antigenicity of Leishmania species ribosomal proteins (LRPs). To accomplish this, Leishmania infantum ribosomes were biochemically purified from promastigote cytosolic extracts, and their reactivities were analyzed by using the sera from dogs naturally infected with L. infantum. Since antibodies reacting against different ribosomal proteins were observed in all the serum samples obtained from dogs with symptomatic visceral leishmaniasis tested, we have analyzed the potential usefulness of the LRP extracts in the development of an enzyme-linked immunosorbent assay (ELISA) for the serodiagnosis of canine visceral leishmaniasis (CVL) in an area of Brazil where visceral leishmaniasis is endemic due to infection by Leishmania chagasi. A comparative ELISA with crude soluble Leishmania chagasi antigen (SLA) and L. infantum LRPs was performed. LRP- and SLA-based ELISAs gave similar sensitivities for the diagnosis of symptomatic CVL, but the LRP extract provided a very high sensitivity for the detection of oligosymptomatic and asymptomatic dogs. In addition, an LRP-based ELISA showed a higher specificity when the sera from dogs harboring other infections were included in the analysis. The LRP antigen displayed no cross-reactivity with sera from dogs that had any of the other diseases tested, notably, Chagas' disease. Our findings suggest that LRPs are a potential tool for the diagnosis of CVL and will be particularly useful for the diagnosis of asymptomatic CVL.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19812259      PMCID: PMC2786384          DOI: 10.1128/CVI.00295-09

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  48 in total

1.  Presence of antibodies in the aqueous humour and cerebrospinal fluid during Leishmania infections in dogs. Pathological features at the central nervous system.

Authors:  M Garcia-Alonso; C G Nieto; A Blanco; J M Requena; C Alonso; I Navarrete
Journal:  Parasite Immunol       Date:  1996-11       Impact factor: 2.280

2.  Protective immunization against visceral leishmaniasis using Leishmania sterol 24-c-methyltransferase formulated in adjuvant.

Authors:  Yasuyuki Goto; Lisa Y Bogatzki; Sylvie Bertholet; Rhea N Coler; Steven G Reed
Journal:  Vaccine       Date:  2007-08-20       Impact factor: 3.641

Review 3.  Evolutionarily conserved proteins as prominent immunogens during Leishmania infections.

Authors:  J M Requena; C Alonso; M Soto
Journal:  Parasitol Today       Date:  2000-06

4.  A retrospective clinical study of canine leishmaniasis in 150 dogs naturally infected by Leishmania infantum.

Authors:  P Ciaramella; G Oliva; R D Luna; L Gradoni; R Ambrosio; L Cortese; A Scalone; A Persechino
Journal:  Vet Rec       Date:  1997-11-22       Impact factor: 2.695

Review 5.  Leishmaniasis.

Authors:  B L Herwaldt
Journal:  Lancet       Date:  1999-10-02       Impact factor: 79.321

Review 6.  Vaccines for leishmaniasis in the fore coming 25 years.

Authors:  Clarisa B Palatnik-de-Sousa
Journal:  Vaccine       Date:  2008-01-30       Impact factor: 3.641

7.  Serological survey of Leishmania infection in dogs from the municipality of Peso da Régua (Alto Douro, Portugal) using the direct agglutination test (DAT) and fast agglutination screening test (FAST).

Authors:  Luís Cardoso; Henk D F H Schallig; Francisco Neto; Nel Kroon; Manuela Rodrigues
Journal:  Acta Trop       Date:  2004-07       Impact factor: 3.112

Review 8.  Canine leishmaniosis--new concepts and insights on an expanding zoonosis: part two.

Authors:  Guadalupe Miró; Luis Cardoso; Maria Grazia Pennisi; Gaetano Oliva; Gad Baneth
Journal:  Trends Parasitol       Date:  2008-07-04

9.  Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection.

Authors:  Eduardo Antonio Ferraz Coelho; Carlos Alberto Pereira Tavares; Fernando Aécio Amorim Carvalho; Karina Figueiredo Chaves; Kadima Nayara Teixeira; Rafaela Chitarra Rodrigues; Hugues Charest; Greg Matlashewski; Ricardo Tostes Gazzinelli; Ana Paula Fernandes
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

Review 10.  Leishmania model for microbial virulence: the relevance of parasite multiplication and pathoantigenicity.

Authors:  Kwang-Poo Chang; Steven G Reed; Bradford S McGwire; Lynn Soong
Journal:  Acta Trop       Date:  2003-03       Impact factor: 3.112

View more
  12 in total

1.  Proteins Selected in Leishmania (Viannia) braziliensis by an Immunoproteomic Approach with Potential Serodiagnosis Applications for Tegumentary Leishmaniasis.

Authors:  Mariana C Duarte; Daniel C Pimenta; Daniel Menezes-Souza; Rubens D M Magalhães; João L C P Diniz; Lourena E Costa; Miguel A Chávez-Fumagalli; Paula S Lage; Daniela C Bartholomeu; Maria Julia M Alves; Ana Paula Fernandes; Manuel Soto; Carlos A P Tavares; Denise U Gonçalves; Manoel O C Rocha; Eduardo A F Coelho
Journal:  Clin Vaccine Immunol       Date:  2015-09-16

Review 2.  A new Leishmania-specific hypothetical protein and its non-described specific B cell conformational epitope applied in the serodiagnosis of canine visceral leishmaniasis.

Authors:  Daniela P Lage; Vívian T Martins; Mariana C Duarte; Lourena E Costa; Esther Garde; Laura M Dimer; Amanda C S Kursancew; Miguel A Chávez-Fumagalli; Danielle F de Magalhães-Soares; Daniel Menezes-Souza; Bruno M Roatt; Ricardo A Machado-de-Ávila; Manuel Soto; Carlos A P Tavares; Eduardo A F Coelho
Journal:  Parasitol Res       Date:  2016-01-19       Impact factor: 2.289

3.  Subtractive phage display selection from canine visceral leishmaniasis identifies novel epitopes that mimic Leishmania infantum antigens with potential serodiagnosis applications.

Authors:  Lourena E Costa; Mayara I S Lima; Miguel A Chávez-Fumagalli; Daniel Menezes-Souza; Vivian T Martins; Mariana C Duarte; Paula S Lage; Eliane G P Lopes; Daniela P Lage; Tatiana G Ribeiro; Pedro H R Andrade; Danielle F de Magalhães-Soares; Manuel Soto; Carlos A P Tavares; Luiz R Goulart; Eduardo A F Coelho
Journal:  Clin Vaccine Immunol       Date:  2013-11-20

4.  A Leishmania-specific hypothetical protein expressed in both promastigote and amastigote stages of Leishmania infantum employed for the serodiagnosis of, and as a vaccine candidate against, visceral leishmaniasis.

Authors:  Vivian T Martins; Mariana C Duarte; Miguel A Chávez-Fumagalli; Daniel Menezes-Souza; Cecília S P Coelho; Danielle F de Magalhães-Soares; Ana Paula Fernandes; Manuel Soto; Carlos A P Tavares; Eduardo A F Coelho
Journal:  Parasit Vectors       Date:  2015-07-11       Impact factor: 3.876

5.  Identification of proteins in promastigote and amastigote-like Leishmania using an immunoproteomic approach.

Authors:  Vinicio T S Coelho; Jamil S Oliveira; Diogo G Valadares; Miguel A Chávez-Fumagalli; Mariana C Duarte; Paula S Lage; Manuel Soto; Marcelo M Santoro; Carlos A P Tavares; Ana Paula Fernandes; Eduardo A F Coelho
Journal:  PLoS Negl Trop Dis       Date:  2012-01-17

6.  Mapping B-cell epitopes for the peroxidoxin of Leishmania (Viannia) braziliensis and its potential for the clinical diagnosis of tegumentary and visceral leishmaniasis.

Authors:  Daniel Menezes-Souza; Tiago Antônio de Oliveira Mendes; Ronaldo Alves Pinto Nagem; Thaís Teodoro de Oliveira Santos; Ana Luíza Teixeira Silva; Marcelo Matos Santoro; Silvio Fernando Guimarães de Carvalho; Eduardo Antônio Ferraz Coelho; Daniella Castanheira Bartholomeu; Ricardo Toshio Fujiwara
Journal:  PLoS One       Date:  2014-06-12       Impact factor: 3.240

7.  Mimotope-based vaccines of Leishmania infantum antigens and their protective efficacy against visceral leishmaniasis.

Authors:  Lourena Emanuele Costa; Luiz Ricardo Goulart; Nathália Cristina de Jesus Pereira; Mayara Ingrid Sousa Lima; Mariana Costa Duarte; Vivian Tamietti Martins; Paula Sousa Lage; Daniel Menezes-Souza; Tatiana Gomes Ribeiro; Maria Norma Melo; Ana Paula Fernandes; Manuel Soto; Carlos Alberto Pereira Tavares; Miguel Angel Chávez-Fumagalli; Eduardo Antonio Ferraz Coelho
Journal:  PLoS One       Date:  2014-10-15       Impact factor: 3.240

8.  Towards a more precise serological diagnosis of human tegumentary leishmaniasis using Leishmania recombinant proteins.

Authors:  Ana Paula Souza; Manuel Soto; Jackson M L Costa; Viviane S Boaventura; Camila I de Oliveira; Juqueline R Cristal; Manoel Barral-Netto; Aldina Barral
Journal:  PLoS One       Date:  2013-06-12       Impact factor: 3.240

9.  Antigenicity and protective efficacy of a Leishmania amastigote-specific protein, member of the super-oxygenase family, against visceral leishmaniasis.

Authors:  Vivian T Martins; Miguel A Chávez-Fumagalli; Lourena E Costa; Adriana M C Canavaci; Adriana M C C Martins; Paula S Lage; Daniela P Lage; Mariana C Duarte; Diogo G Valadares; Rubens D M Magalhães; Tatiana G Ribeiro; Ronaldo A P Nagem; Wanderson D Darocha; Wiliam C B Régis; Manuel Soto; Eduardo A F Coelho; Ana Paula Fernandes; Carlos A P Tavares
Journal:  PLoS Negl Trop Dis       Date:  2013-03-28

10.  Coadministration of the Three Antigenic Leishmania infantum Poly (A) Binding Proteins as a DNA Vaccine Induces Protection against Leishmania major Infection in BALB/c Mice.

Authors:  Manuel Soto; Laura Corvo; Esther Garde; Laura Ramírez; Virginia Iniesta; Pedro Bonay; Carlos Gómez-Nieto; Víctor M González; M Elena Martín; Carlos Alonso; Eduardo A F Coelho; Aldina Barral; Manoel Barral-Netto; Salvador Iborra
Journal:  PLoS Negl Trop Dis       Date:  2015-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.